Predictive and prognostic markers are at the forefront of personalised cancer care, offering clinicians the ability to both anticipate a patient’s response to specific therapies and gauge the likely ...
A number of tumor and host characteristics have been found useful in predicting the risk of recurrence and the chance of death from breast cancer following primary surgery. Traditional prognostic ...
Phase II trial of neoadjuvant nivolumab and SOX in resectable gastric/gastroesophageal junction cancer: Therapeutic response and biomarker correlations. This is an ASCO Meeting Abstract from the 2025 ...
These caveats should lead clinicians to be cautious when deciding on a therapeutic strategy based on MGMT methylation status alone. However, because it is an important prognostic and predictive factor ...
OCTOPUS: A retrospective, multicenter study of real-world cabozantinib treatment of patients with advanced renal cell carcinoma in France—Subgroup analyses of treatment sequences and optimization.
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced that three abstracts will be presented at the San Antonio Breast Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results